Cart
sales@molnova.com
Pyroxamide
CAS No. 382180-17-8
Pyroxamide ( —— )
Catalog No. M20956 CAS No. 382180-17-8
Pyroxamide is an histone deacetylases (HDACs) inhibitor with antineoplastic properties ( HDAC1;IC50: 0.1-0.2 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 39 | Get Quote |
|
| 10MG | 68 | Get Quote |
|
| 25MG | 146 | Get Quote |
|
| 50MG | 251 | Get Quote |
|
| 100MG | 443 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePyroxamide
-
NoteResearch use only not for human use.
-
Brief DescriptionPyroxamide is an histone deacetylases (HDACs) inhibitor with antineoplastic properties ( HDAC1;IC50: 0.1-0.2 μM).
-
DescriptionPyroxamide is an histone deacetylases (HDACs) inhibitor with antineoplastic properties ( HDAC1;IC50: 0.1-0.2 μM).
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number382180-17-8
-
Formula Weight265.31
-
Molecular FormulaC13H19N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (471.15 mM)
-
SMILESO=C(CCCCCCC(=O)Nc1cccnc1)NO
-
Chemical NameN1-hydroxy-N8-(pyridin-3-yl)octanediamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Butler L M Webb Y Agus D B et al. Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide an inhibitor of histone deacetylase[J]. Clinical Cancer Research 2001 7(4):962-970.
molnova catalog
related products
-
SKLB-23bb
SKLB-23bb is an orally bioavailable HDAC6-selective inhibitor and also has microtubule-disrupting ability.
-
BRD6688
BRD6688 is a selective HDAC2 inhibitor that acts by enhancing the learning and memory processes.
-
Exifone
Exifone is a mixed, nonessential activator of HDAC1 that is capable of binding to both free and substrate-bound enzyme, resulting in an increased relative maximal rate of HDAC1-catalyzed deacetylation.
